Richard R. DeLuca, EVP&Pres, Merck Animal Heallth at Merck & Co., Inc. (MRK), sold 45,320 shares at $130.43 ($5.9M) on 2026-08-10, disclosed to the SEC on 2026-08-12.
Open-market sale of $5.9M MRK by EVP&Pres, Merck Animal Heallth. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.43 | 20,784 | $2.7M | 45.6% |
| 2 | $131.33 | 7,410 | $973K | 16.4% |
| 3 | $132.35 | 5,427 | $718K | 12.1% |
| 4 | $131.61 | 11,099 | $1.5M | 24.6% |
| 5 | $132.04 | 600 | $79K | 1.3% |
| Total | $131.12 avg | 45,320 |
| $5.9M |
| 100% |
| Filing → |
| MRK | SELL | 2023-11-09 | $9.2M | — | Filing → |
| MRK | SELL | 2023-05-02 | $25.1M | — | Filing → |
| MRK | SELL | 2022-11-01 | $33.0M | — | Filing → |